Business
Citi slaps buy rating on ResMed shares
Image source: Getty Images
ResMed Inc (ASX: RMD) shares are in the red so far in 2025.
After slipping from 52-week highs of $40.50 in January, shares in the respiratory device company currently fetch $35.71 apiece.
This brings the stock back to its September 2024 levels.
With shares at these…
Continue Reading
-
General15 hours agoFour charged over alleged six-hour gang rape of girl in south-west Sydney
-
Business18 hours agoAiming for rock-solid retirement income? I’d buy these two ASX shares
-
Noosa News14 hours agoCharlie the therapy dog reduces stress – Proctor
-
Business18 hours agoWarren Buffett says buy this index fund. It could turn $400 per month into $851,800 with help from Apple, Nvidia, and Tesla.